Abiopharma

🔍 ROTHBLATT MARTINE A (Executive)

Company: UNITED THERAPEUTICS Corp (UTHR)

Report Date: 2026-07-31

Detailed Transactions and Holdings:

• Acquired 9,500 shares of Common Stock at $135.42 per share (Direct)
  Date: 2026-07-31 | Code: M | equity_swap_involved: false | shares_owned_after: 333,943.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 365 shares of Common Stock at $514.8231 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 333,578.00 | transaction_form_type: 4 | Footnotes: F1, F3, F2
• Sold 857 shares of Common Stock at $515.8389 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 332,721.00 | transaction_form_type: 4 | Footnotes: F1, F4, F2
• Sold 1,133 shares of Common Stock at $516.9427 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 331,588.00 | transaction_form_type: 4 | Footnotes: F1, F5, F2
• Sold 1,215 shares of Common Stock at $518.0006 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 330,373.00 | transaction_form_type: 4 | Footnotes: F1, F6, F2
• Sold 1,266 shares of Common Stock at $519.0553 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 329,107.00 | transaction_form_type: 4 | Footnotes: F1, F7, F2
• Sold 2,627 shares of Common Stock at $520.1182 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 326,480.00 | transaction_form_type: 4 | Footnotes: F1, F8, F2
• Sold 1,517 shares of Common Stock at $520.8032 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 324,963.00 | transaction_form_type: 4 | Footnotes: F1, F9, F2
• Sold 282 shares of Common Stock at $521.5222 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 324,681.00 | transaction_form_type: 4 | Footnotes: F1, F10, F2
• Sold 238 shares of Common Stock at $522.8759 per share (Direct)
  Date: 2026-07-31 | Code: S | equity_swap_involved: false | shares_owned_after: 324,443.00 | transaction_form_type: 4 | Footnotes: F1, F11, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-31 | Code: H | shares_owned_after: 40,513.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-31 | Code: H | nature_of_ownership: by Spouse | shares_owned_after: 166.00
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-31 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 249,108.00 | Footnotes: F12
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-31 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 45,596.00 | Footnotes: F13
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-07-31 | Code: H | nature_of_ownership: by Trust | shares_owned_after: 8,902.00 | Footnotes: F14
• Sold 9,500 shares of Stock Option at $135.42 per share (Derivative)
  Date: 2026-07-31 | Code: M | Expires: 2027-03-15 | Exercise: 2023-03-15 | equity_swap_involved: false | shares_owned_after: 227,410.00 | transaction_form_type: 4 | Footnotes: F1, F15

Footnotes:

• F1: This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 15, 2027; or (b) December 31, 2026.
• F10: This transaction was executed in multiple trades at prices ranging from $521.49 to $522.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F11: This transaction was executed in multiple trades at prices ranging from $522.50 to $523.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F12: Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F13: Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F14: Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.
• F15: Stock options held in a family trust as to which the Reporting Person shares investment power and the Reporting Person and immediate family members are beneficiaries.
• F2: Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries.
• F3: This transaction was executed in multiple trades at prices ranging from $514.35 to $515.30. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F4: This transaction was executed in multiple trades at prices ranging from $515.40 to $516.37. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F5: This transaction was executed in multiple trades at prices ranging from $516.40 to $517.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F6: This transaction was executed in multiple trades at prices ranging from $517.45 to $518.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F7: This transaction was executed in multiple trades at prices ranging from $518.46 to $519.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F8: This transaction was executed in multiple trades at prices ranging from $519.46 to $520.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
• F9: This transaction was executed in multiple trades at prices ranging from $520.46 to $521.26. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.